Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study Assessing Whether Immunoscore Colon Test Impacts the Choice of Adjuvant Chemotherapy, in a Multidisciplinary Meeting, for Treating Non-metastatic Colon Cancer Patients After Curative-intent Surgery

NCT03946033 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT03946033
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03946033 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study Assessing Whether Immunoscore Colon Test Impacts the Choice of Adjuvant Chemotherapy, in a Multidisciplinary Meeting, for Treating Non-metastatic Colon Cancer Patients After Curative-intent Surgery
Lead sponsor
UNICANCER
Phase
Not applicable
Overall status
Withdrawn
Start date
May 31, 2019
Completion date
February 28, 2021
Enrollment
0 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

colonic neoplasms